Study presented at EHA21 looks at Pfizer/BioNTech SARS-COV-2 vaccine impairment in immunosuppressed patients
The European Hematology Association held their virtual congress from 9-17 June – it remains online until 15 August here. Many studies were presented, key among them was one titled: Humoral Response to the Pfizer/BioNTech BNT162b2 Vaccine Is Impaired in Patients Receiving CAR-T or High-Intensity Immunosuppressive Therapy. In the study the researchers evaluated the efficacy and […]
